Publikationen in Zusammenarbeit mit Forschern von Instituto de Investigación Sanitaria Fundación Jiménez Díaz (9)

2024

  1. HMGA1 regulates trabectedin sensitivity in advanced soft-tissue sarcoma (STS): A Spanish Group for Research on Sarcomas (GEIS) study

    Cellular and Molecular Life Sciences, Vol. 81, Núm. 1

  2. Malondialdehyde Serum Levels in a Full Characterized Series of 430 Rheumatoid Arthritis Patients

    Journal of Clinical Medicine, Vol. 13, Núm. 3

  3. Prognostic impact of tumor location and gene expression profile in sporadic desmoid tumor

    European Journal of Cancer, Vol. 209

  4. Renal Disease in Metabolic Syndrome: the Hidden Role of Intrarenal Ischemia

    Kidney International Reports, Vol. 9, Núm. 5, pp. 1419-1428

  5. Restored glyoxylate metabolism after AGXT gene correction and direct reprogramming of primary hyperoxaluria type 1 fibroblasts

    iScience, Vol. 27, Núm. 4

2023

  1. Corrigendum to ‘Chemotherapy in patients with localized angiosarcoma of any site: A retrospective european study’ [Eur J Cancer 171 (2022) 183–192, (S0959804922002696), (10.1016/j.ejca.2022.04.030)]

    European Journal of Cancer

  2. Malondialdehyde Serum Levels in Patients with Systemic Sclerosis Relate to Dyslipidemia and Low Ventricular Ejection Fraction

    Antioxidants, Vol. 12, Núm. 9

  3. Relationship between Malondialdehyde Serum Levels and Disease Features in a Full Characterized Series of 284 Patients with Systemic Lupus Erythematosus

    Antioxidants, Vol. 12, Núm. 8

2022

  1. Chemotherapy in patients with localized angiosarcoma of any site: A retrospective european study

    European Journal of Cancer, Vol. 171, pp. 183-192